Filing Details
- Accession Number:
- 0001179110-14-000786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-01-09 19:13:39
- Reporting Period:
- 2014-01-08
- Filing Date:
- 2014-01-09
- Accepted Time:
- 2014-01-09 19:13:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
792977 | Amag Pharmaceuticals Inc. | AMAG | Pharmaceutical Preparations (2834) | 042742593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1537668 | G Christopher White | 1100 Winter Street Waltham MA 02451 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-01-08 | 2,000 | $23.91 | 26,834 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-09 | 1,700 | $20.61 | 25,134 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-09 | 100 | $21.40 | 25,034 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-01-09 | 200 | $22.41 | 24,834 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
- The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.77 - $24.07. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $20.12 - $21.00. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
- The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $22.40 - $22.41. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.